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ABSTRACT 
 
With advancing science and technology, new futuristic technologies have been upcoming that are having a 
greater impact on the pharmaceutical and biomedical fields. Many lipids and polymer of natural and syn-
thetic origin have spread horizons enabling to reach in fabricating delivery systems for unmet medical 
needs. In this modern biomedicine era, we must outline and scrutiny the roles of these biomaterials and the 
modern technologies that are shaping up the advancing medicines. The real challenges in modulating, fine-
tuning the biomaterials for their bioactive properties are vital for assessing the in-vivo performance of the 
developed systems. Therefore, the present review discusses the detailed analysis of the current research 
reported in the technologies of utilizing the lipids, polymers, and their role in delivering the drugs, genes, 
and designing advanced implantable medical devices. The scrutiny also focuses on key optimization tools, 
analytical methods, formulation, and biomedical techniques helpful in developing the solutions that can be 
administered different routes in different therapeutic indications. 
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INTRODUCTION 
In the current scenario, many efforts are utilized to 
use the power of many lipid and polymer based drug 
delivery systems, as it gives the proper means for 
site-specific targeting; with time specific controlled 
delivery of genes/ drugs having various molecular 
weights, either medium or large, along with bioactive 
[1,2]. Furthermore, sparingly water-soluble drugs (II/ 
IV) are real challenges for the formulation specialist 
about solubility, dissolution and bioavailability. Lipid 
or polymer-based delivery systems are effective in 
size dependent attributes therefore gained a lot of at-
tention. Also, these biomaterials or lipids or polymers 
have taken the lead due to its advantages of having 
great degree of biocompatibility, biodegradation and 
tunability. These systems are commercially viable to 
formulate pharmaceuticals for topical [3], oral [4], par-
enteral route delivery [5]. Lipid formulations can be 
modified into different formulations such as Prolipo-
somes [6], Microparticles [7], Solid lipid Nanoparticles 
[8], Nanoemulsion [9], Nanocrystals [10], Nanowires 
[11,12], Self-nano emulsifying drug delivery system 
(SNEDDS) [13], In-situ gels [14], Nanofibers [15], Nano-
ethosomes [16], various that meet the requirements as 
per the disease, route of administration. They really 
safeguard the total cost, long-term product stability, 
severe toxicity, and better efficacy. Lipid oriented car-
riers are safe, efficient therefore right candidates for 
the formulation of drugs, as well as vaccines, diagnos-
tic, and nutraceutical [17]. Therefore, lipid based deliv-
ery systems have gained more importance in current 
years due to their capability to improvise the solubil-
ities and bioavailability’s of various drugs and chem-
ical compounds (Figure 1). 
Success of lipid-based delivery carrier is upon the 
empirical experience. Systematic physicochemical in-
vestigation of structures and stability’s does not help 
to pace up the progression of newer and improve for-
mulation but helps to know complex mechanism that 
M. Hima Bindu et al., (2020) Int. J. Res. Pharm. Sci & Tech., 2(1), 07-11 
8  Rubatosis Publications | International Journal of Research in Pharmaceutical Sciences and Technology 
 
governs the interactions between the lipid’s carrier 
and the human cell [18]. Therefore, they are consid-
ered as safer, efficiently for carrier designed for both 
drug and gene delivery. (ii) They are being evaluated 
to be used for protein and peptide, DNA, siRNA and 
cell specific deliveries [19]. Lipids are recognized as 
versatile excipient class that provides the formulator 
with much option for improvising and to control the 
absorption of many poorly soluble drug. (iii) Lipid-
based formulations, that are end products of innova-
tions, those have not only exhibited their use for over-
coming the poor and altered GIT absorption of poor 
soluble or lipophilic drug, but even minimized the ef-
fect of food on the absorption, distribution, metabo-
lism and excretion of many active drugs. Inspite of 
these factsheet, oral marketed products having lipid 
oriented dosage form are being out-numbered 26 to 
2 by traditional formulations [20].  
Many accountability needs to be made to the charac-
terize different lipid based formulations that are 
available so that protocols and process methods are 
established that help to identify the key moiety for-
mulation at a beginning stage. Various technologies 
needs to be jotdown for handling the solubility state 
of the drugs in-vivo, and importantly in-vitro method 
are required for identifying the turbulent changes 
that are anticipated in the GIT. Careful considerations 
are required in terms of both physiochemical drug 
stability within lipid carriers and their interaction 
with capsule shells is important to be established. 
Whilst these present challenges there is a great po-
tential in the use of lipid formulations [21]. The prefer-
ence for futuristic research is to conduct bioavailabil-
ity study in preclinical model and to perform more 
applied studies on understanding the mechanisms of 
action of these lipid formulations. 
Role of biomaterials in controlled drug delivery 
The progress in innovative strategies for controlled/ 
sustained or prolonged drug delivery is vital tool for 
enhancement of local drug activity at target site. Ba-
sically, the transition time of fluids and pH value in 
GIT represents a characteristic behavior with in-
crease in pH from the stomach (pH 1-2.2) to small- 
intestine (pH 4.5-5) and along the jejunum /ileum 
(lower part of the small intestine, pH 6.2) and further 
reaches a pH 7.0 in the colon system [22]. The protona-
tion provided by the stomach (low pH region) im-
proves the water solubility of drugs while the high pH 
at the intestine induces deprotonation and subse-
quent decrease in the solubility of the drug. The en-
capsulation of drugs by enteric coating contributes 
with a complementary behavior: at low pH, the solu-
bility of enteric coating is negligible, provoking a 
strong reduction in the permeability of drugs along 
with the coating. At high pH, the enteric coating be-
comes water-soluble in association with a reduction 
in the drug solubility. As a consequence, the profile of 
drug release tends to be independent [23]. 
The use of electrospun nanofibers for controlled 
drug-release provides wide advantage comparative 
to the loading of various active drugs in the polymer 
templates by electrospinning technology. The en-
hancement in the bioavailability of the active drug is 
linked with reduction in side effects (such as nausea, 
diarrhea, pain). In this prospection, electrospun nan-
ofibers are been progressing and applied in soft/ 
hard tissue engineering, wound-dressing, and 
drug/gene delivery [24]. The popularity for a particu-
lar application is attributed due to the high-surface to 
volume-ratio; small-diameter; and high-porosity; 
that aid for the growth of absorption of water by lip-
ophilic drugs [25]. 
Polymers are incredible being utilized in various 
cross functional technologies aid to their robust na-
ture, versatility, and ease to process. They act as good 
host substrates for nanocomposites and nanomateri-
als and tunable as per requirement. Polymeric nano-
composite require filler in the nanoscale and exhibit 
significant specific characteristics than in bulkness 
because of the changes in the interplay by host sub-
strates; morphology and aids huge interests in non-
profit academia and profitable industries. As com-
mon features of polymer, they have low-strength, 
coupled with reduced impact-strength, that can be 
improved with the upcoming polymeric nanocompo-
sitions. Many reports have addressed the progres-
sions in the nanocomposite’s applications [26]. 
Polymers in Biomedical applications 
Biodegradable biomaterials or polymer exhibit a 
wide history that can overcome the synthetic prod-
ucts use. The field of synthetic polymers is existed 
since the 1981s. From that time, there is a slow and 
gradual growth because of its outputs that are poten-
tially connected to the major of popular products. 
This multidisciplinary area has components of mate-
rial sciences, synthetic biology, chemistry, modern 
medicine, soft/ hard tissue engineering. The ad-
vantage of polymers in this area is that they can be 
tailored from the viewpoint of their chemical, physi-
cal, and surface properties, to enable good cell adhe-
sion and proliferation in vivo, maintenance of their 
properties for a given time, and then degradation 
with no harmful effects in the body [24]. These are 
opted for a wide application, but majority of applica-
tions are in tissue engineering and drug delivery. Bi-
omaterials with enhanced biocompatibility are effec-
tive to be used as nanoscaffolds for body application. 
Inspite of the success of renewable source polymer, 
such as chitosan [27], alginates [28], PLGA [29], okra [30] 
in the last years, majority of biomaterial are in the 
commercial scale up. In the process of improving 
chemical, physical and thermo-mechanical proper-
ties, nanofibers are incorporated into biological 
based polymer substrates. This review highlights 
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provides a wide platform for junior scientist and sen-
ior researcher’s in the fields of biological origin poly-
mers and nanocomposites to establish their state-of-
the-art work concerned to the transformation of nat-
ural resources into value-added drug formulations, 
implantable medical devices. Further modifications 
and specific preparations of these new bio-origin pol-
ymers/ lipids, and their characterizations and appli-
cations are profound. This review article even uncov-
ers the development of biological source lipids, poly-
mers and nanocomposites that are procured, includ-
ing newer technologies that are related to their ex-
traction, isolation, synthesis, processing’s, character-
izations and applications [31]. 
CONCLUSION 
Therefore, the present study is focused on upbringing 
the usefulness and important aspects of how best the 
lipids and polymers can greatly help in formulating 
multiple solutions for delivering gene, drug, via dif-
ferent routes. There are several other biomaterials 
such as alginates, chitosan, that needs extensive anal-
ysis for their applications in medical device indus-
tries. Overall, the article explains the importance of 
these materials for framing useful strategies that can 
greatly effect the health care of the humans. 
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